Ocular Therapeutix logo
Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.54
0.00 (0.00%)
Oct 12, 2026, 10:47 AM EDT - Market open

Ocular Therapeutix Revenue

Ocular Therapeutix had revenue of $13.48M in the quarter ending June 30, 2026, with 0.12% growth. This brings the company's revenue in the last twelve months to $52.05M, down -8.14% year-over-year. In the year 2025, Ocular Therapeutix had annual revenue of $51.95M, down -18.47%. That makes Ocular Therapeutix the 27,659th largest company in the world by revenue and 3,759th in the United States.

Revenue (ttm)
$52.05M
Revenue Growth
-8.14%
P/S Ratio
31.81
Revenue / Employee
$160,169
Employees
325
Market Cap
1.66B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202551.95M-11.77M-18.47%
Dec 31, 202463.72M5.28M9.03%
Dec 31, 202358.44M6.95M13.49%
Dec 31, 202251.49M7.97M18.32%
Dec 31, 202143.52M26.12M150.08%
Dec 31, 202017.40M13.18M311.71%
Dec 31, 20194.23M2.24M112.41%
Dec 31, 20181.99M67.00K3.48%
Dec 31, 20171.92M36.00K1.91%
Dec 31, 20161.89M137.00K7.83%
Dec 31, 20151.75M978.00K126.68%
Dec 31, 2014772.00K--
Dec 31, 2013---
Dec 31, 201210.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ultragenyx Pharmaceutical717.00M
Innoviva440.00M
UroGen Pharma188.73M
Nuvation Bio169.90M
Septerna98.88M
Stoke Therapeutics27.59M
uniQure18.67M
Absci1.56M
Revenue Rankings